Anti-Sprouty 2抗体- Aminoterminal end (ab50317)

发表研究结果有使用 ab50317?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab50317 被引用在 9 文献中.

  • Ma X  et al. Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. Carcinogenesis 34:1216-23 (2013). Mouse . PubMed: 23385064
  • Andreadi C  et al. The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway. Genes Dev 26:1945-58 (2012). PubMed: 22892241
  • Das M  et al. The role of JNK in the development of hepatocellular carcinoma. Genes Dev 25:634-45 (2011). WB ; Mouse . PubMed: 21406557
  • Miraoui H  et al. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Hum Mol Genet 19:1678-89 (2010). WB, IP ; Human . PubMed: 20124286
  • Hatley ME  et al. Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21. Cancer Cell 18:282-93 (2010). WB ; Mouse . PubMed: 20832755
  • Scott CL  et al. Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock. Am J Physiol Lung Cell Mol Physiol 299:L455-71 (2010). WB ; Mouse . PubMed: 20622121
  • Taniguchi K  et al. Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. PLoS One 4:e5467 (2009). WB ; Mouse . PubMed: 19424491
  • Zhou S  et al. NPAS3 is a trachealess homolog critical for lung development and homeostasis. Proc Natl Acad Sci U S A 106:11691-6 (2009). IHC-P ; Mouse . PubMed: 19581591
  • Friday BB  et al. BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins. Cancer Res 68:6145-53 (2008). WB ; Human . PubMed: 18676837

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"